Obviously a fail with our tbi trial will be a disappointment, but any sell off should be seen as a buying opportunity.
As we know there has been much interest from big pharma following the Retts results, and there will have been much more following fragile X. Bell Potter reasonably expects a $680m deal on these results alone.
So neu is currently undervalued on what we have already, regardless of any tbi upside.
Personally I'm very excited about the coming results.
Cheers
TBI results - not long to go, page-2
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.27 |
Change
0.650(3.15%) |
Mkt cap ! $2.718B | |||
| Open | High | Low | Value | Volume |
| $20.84 | $21.56 | $20.76 | $7.760M | 364.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1378 | $21.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.29 | 218 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |